RaySearch RayStation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (InverseArc 1.0) (Radiation therapy treatment planning system) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Emergo Asia Pacific Pty Ltd T/a Emergo Australia 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-01185-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2016-09-09
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Two issues have been identified with the dose calculation when using a region of interest (roi) of type fixation or support with material override within the patient outline (external roi) in raystation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (inversearc 1.0). these are: - when an roi with material override overlaps a fixation or support roi, the material used for dose calculation in the overlapping region may not be as intended.- when a support or fixation roi overlaps the patient outline (external roi) in a dose grid voxel along the outer surface of the patient outline, the density used for dose calculation in that voxel may not be as intended.These issues have not caused any patient mistreatment or other incidents. however, the user must be aware of this information to avoid incorrect dose calculations during treatment planning.
  • 조치
    A correction of these issues will be available in the next version of RayStation, scheduled for market release in December 2016. In the interim, users are advised that not to use ROIs of type Fixation or Support within the patient outline. Always use other ROI types for material override within the External ROI. A small overlap with the External ROI is acceptable if the Fixation or Support ROI is mainly outside the External ROI.

Device

  • 모델명 / 제조번호(시리얼번호)
    RaySearch RayStation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (InverseArc 1.0) (Radiation therapy treatment planning system)ARTG Number: 195288
  • Manufacturer

Manufacturer